Please Wait.....
Report
Next-generation Sequencing Technology Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2030
Market Report I 2023-09-04 I 255 Pages I Infinium Global Research and Consulting Solutions
The report on the global next-generation sequencing technology market provides qualitative and quantitative analysis for the period from 2021-2030. The global next-generation sequencing technology market was valued at USD 8.23 billion in 2022 and is expected to reach USD 43.41 billion in 2030, with a CAGR of 20.94% during the forecast period 2023-2030. The study on next-generation sequencing technology market covers the analysis of the leading geographies such as North America, Europe, Asia Pacific, and RoW for the period of 2021-2030.
The Next-generation Sequencing (NGS) technology market refers to the rapidly growing industry centered around advanced DNA sequencing techniques that enable the high-throughput, cost-effective analysis of genomic information. NGS has revolutionized genomics research, clinical diagnostics, and personalized medicine by allowing researchers and healthcare professionals to decode an individual's entire genome, transcriptome, or epigenome quickly and accurately. This technology has a wide range of applications, from studying genetic variations and identifying disease-causing mutations to monitoring treatment responses and tracking the spread of infectious diseases. Additionally, the driving factor for the growth of the NGS technology market is its increasing adoption in clinical diagnostics. As precision medicine gains momentum, NGS plays a crucial role in identifying genetic markers associated with diseases, enabling more accurate diagnoses and personalized treatment plans. The ability to sequence entire genomes or targeted gene panels at a reasonable cost has led to the integration of NGS into routine clinical practice, particularly in oncology, rare disease diagnosis, and reproductive health. Moreover, ongoing advancements in NGS platforms and bioinformatics tools continue to enhance the technology's reliability and scalability, further fueling its adoption in healthcare, research, and other fields, and contributing to the market's expansion.
The clinical application segment is emerging as the fastest-growing sector in the Next-generation Sequencing (NGS) technology market. This rapid expansion is driven by the increasing integration of NGS into routine clinical diagnostics and healthcare practices. NGS offers an invaluable tool for identifying genetic mutations, variants, and biomarkers associated with various diseases, including cancer, rare genetic disorders, and infectious diseases. One major factor fueling this growth is the surge in precision medicine initiatives. Healthcare providers are increasingly adopting NGS to personalize treatment plans based on an individual's unique genetic makeup, thereby improving therapeutic outcomes and reducing adverse effects. Furthermore, the continuous reduction in sequencing costs and advancements in bioinformatics tools have made NGS more accessible to clinical laboratories and healthcare institutions. The COVID-19 pandemic has also accelerated the adoption of NGS for viral genome sequencing, tracking emerging variants, and enhancing diagnostic accuracy. As NGS continues to prove its value in clinical settings, its role in disease diagnosis, treatment selection, and monitoring is expected to expand further, solidifying its position as the fastest-growing segment in the NGS technology market.
Next-generation Sequencing (NGS) technology is increasingly becoming a standard clinical diagnostic procedure. Key factors driving this trend include the growing incidence of chronic and infectious diseases, higher investments in genomics research, and ongoing advancements made by prominent industry leaders. These factors collectively contribute to the anticipated expansion of the market. For instance, according to Canada Cancer Society's statistics in 2022, approximately 6,700 cases of leukemia diagnosed in Canada in 2021, with 4,000 cases occurring in males and 2,700 cases in females. Also, as per the American Cancer Society's data in 2023, it is projected that approximately 59,610 new cases of leukemia and 20,380 new cases of Acute Myeloid Leukemia (AML) will be diagnosed in the United States in 2023. This elevated prevalence of these diseases is contributing to the growing utilization of NGS technology-based devices, consequently propelling market expansion in the region.
Report Findings
1) Drivers
- Growing demand for personalized medicine and research advancements fuel the adoption of next-generation sequencing technology.
- The need for quicker and more efficient sequencing processes drives the next-generation sequencing technology market.
2) Restraints
- High costs and data analysis complexities limit the widespread implementation of next-generation sequencing.
3) Opportunities
- Expansion into clinical diagnostics and emerging markets presents significant growth opportunities for next-generation sequencing technology.
Research Methodology
A) Primary Research
Our primary research involves extensive interviews and analysis of the opinions provided by the primary respondents. The primary research starts with identifying and approaching the primary respondents, the primary respondents are approached include
1. Key Opinion Leaders associated with Infinium Global Research
2. Internal and External subject matter experts
3. Professionals and participants from the industry
Our primary research respondents typically include
1. Executives working with leading companies in the market under review
2. Product/brand/marketing managers
3. CXO level executives
4. Regional/zonal/ country managers
5. Vice President level executives.
B) Secondary Research
Secondary research involves extensive exploring through the secondary sources of information available in both the public domain and paid sources. At Infinium Global Research, each research study is based on over 500 hours of secondary research accompanied by primary research. The information obtained through the secondary sources is validated through the crosscheck on various data sources.
The secondary sources of the data typically include
1. Company reports and publications
2. Government/institutional publications
3. Trade and associations journals
4. Databases such as WTO, OECD, World Bank, and among others.
5. Websites and publications by research agencies
Segment Covered
The global next-generation sequencing technology market is segmented on the basis of technology, application, and end user.
The Global Next-generation Sequencing Technology Market by Technology
- Sequencing by Synthesis
- Ion Semiconductor Sequencing
- Sequencing by Ligation
- Pyrosequencing
- Single-molecule real-time
The Global Next-generation Sequencing Technology Market by Application
- Clinical Application
o Cardiovascular
o Oncology
o Reproductive Health Diagnostics
o Others
- Research Application
o Drug Discovery
o Agriculture & Animal Research
o Others
The Global Next-generation Sequencing Technology Market by End User
- Academic and Research Centers
- Pharmaceutical and Biotechnology Companies
- Hospitals and Clinics
Company Profiles
The companies covered in the report include
- Agilent Technologies, Inc.
- Twist Bioscience
- DNASTAR
- Eurofins Scientific
- F. Hoffmann-La Roche Ltd
- Illumina, Inc.
- Macrogen, Inc.
- PacBio
- QIAGEN
- Thermo Fisher Scientific Inc.
What does this Report Deliver?
1. Comprehensive analysis of the global as well as regional markets of the next-generation sequencing technology market.
2. Complete coverage of all the segments in the next-generation sequencing technology market to analyze the trends, developments in the global market and forecast of market size up to 2030.
3. Comprehensive analysis of the companies operating in the global next-generation sequencing technology market. The company profile includes analysis of product portfolio, revenue, SWOT analysis and latest developments of the company.
4. IGR- Growth Matrix presents an analysis of the product segments and geographies that market players should focus to invest, consolidate, expand and/or diversify.
Table of Content
Chapter 1. Preface
1.1. Report Description
1.2. Research Methods
1.3. Research Approaches
Chapter 2. Executive Summary
2.1. Next-generation Sequencing Technology Market Highlights
2.2. Next-generation Sequencing Technology Market Projection
2.3. Next-generation Sequencing Technology Market Regional Highlights
Chapter 3. Global Next-generation Sequencing Technology Market Overview
3.1. Introduction
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
3.3. Porter's Five Forces Analysis
3.4. IGR-Growth Matrix Analysis
3.4.1. IGR-Growth Matrix Analysis by Technology
3.4.2. IGR-Growth Matrix Analysis by Application
3.4.3. IGR-Growth Matrix Analysis by End User
3.4.4. IGR-Growth Matrix Analysis by Region
3.5. Value Chain Analysis of Next-generation Sequencing Technology Market
Chapter 4. Next-generation Sequencing Technology Market Macro Indicator Analysis
Chapter 5. Company Profiles and Competitive Landscape
5.1. Competitive Landscape in the Global Next-generation Sequencing Technology Market
5.2. Companies Profiles
5.2.1. Agilent Technologies, Inc.
5.2.2. Twist Bioscience
5.2.3. DNASTAR
5.2.4. Eurofins Scientific
5.2.5. F. Hoffmann-La Roche Ltd
5.2.6. Illumina, Inc.
5.2.7. Macrogen, Inc.
5.2.8. PacBio
5.2.9. QIAGEN
5.2.10. Thermo Fisher Scientific Inc.
Chapter 6. Global Next-generation Sequencing Technology Market by Technology
6.1. Sequencing by Synthesis
6.2. Ion Semiconductor Sequencing
6.3. Sequencing by Ligation
6.4. Pyrosequencing
6.5. Single-molecule real-time
Chapter 7. Global Next-generation Sequencing Technology Market by Application
7.1. Clinical Application
7.1.1. Cardiovascular
7.1.2. Oncology
7.1.3. Reproductive Health Diagnostics
7.1.4. Others
7.2. Research Application
7.2.1. Drug Discovery
7.2.2. Agriculture & Animal Research
7.2.3. Others
Chapter 8. Global Next-generation Sequencing Technology Market by End User
8.1. Academic and Research Centers
8.2. Pharmaceutical and Biotechnology Companies
8.3. Hospitals and Clinics
Chapter 9. Global Next-generation Sequencing Technology Market by Region 2023-2030
9.1. North America
9.1.1. North America Next-generation Sequencing Technology Market by Technology
9.1.2. North America Next-generation Sequencing Technology Market by Application
9.1.3. North America Next-generation Sequencing Technology Market by End User
9.1.4. North America Next-generation Sequencing Technology Market by Country
9.1.4.1. The U.S. Next-generation Sequencing Technology Market
9.1.4.1.1. The U.S. Next-generation Sequencing Technology Market by Technology
9.1.4.1.2. The U.S. Next-generation Sequencing Technology Market by Application
9.1.4.1.3. The U.S. Next-generation Sequencing Technology Market by End User
9.1.4.2. Canada Next-generation Sequencing Technology Market
9.1.4.2.1. Canada Next-generation Sequencing Technology Market by Technology
9.1.4.2.2. Canada Next-generation Sequencing Technology Market by Application
9.1.4.2.3. Canada Next-generation Sequencing Technology Market by End User
9.1.4.3. Mexico Next-generation Sequencing Technology Market
9.1.4.3.1. Mexico Next-generation Sequencing Technology Market by Technology
9.1.4.3.2. Mexico Next-generation Sequencing Technology Market by Application
9.1.4.3.3. Mexico Next-generation Sequencing Technology Market by End User
9.2. Europe
9.2.1. Europe Next-generation Sequencing Technology Market by Technology
9.2.2. Europe Next-generation Sequencing Technology Market by Application
9.2.3. Europe Next-generation Sequencing Technology Market by End User
9.2.4. Europe Next-generation Sequencing Technology Market by Country
9.2.4.1. Germany Next-generation Sequencing Technology Market
9.2.4.1.1. Germany Next-generation Sequencing Technology Market by Technology
9.2.4.1.2. Germany Next-generation Sequencing Technology Market by Application
9.2.4.1.3. Germany Next-generation Sequencing Technology Market by End User
9.2.4.2. United Kingdom Next-generation Sequencing Technology Market
9.2.4.2.1. United Kingdom Next-generation Sequencing Technology Market by Technology
9.2.4.2.2. United Kingdom Next-generation Sequencing Technology Market by Application
9.2.4.2.3. United Kingdom Next-generation Sequencing Technology Market by End User
9.2.4.3. France Next-generation Sequencing Technology Market
9.2.4.3.1. France Next-generation Sequencing Technology Market by Technology
9.2.4.3.2. France Next-generation Sequencing Technology Market by Application
9.2.4.3.3. France Next-generation Sequencing Technology Market by End User
9.2.4.4. Italy Next-generation Sequencing Technology Market
9.2.4.4.1. Italy Next-generation Sequencing Technology Market by Technology
9.2.4.4.2. Italy Next-generation Sequencing Technology Market by Application
9.2.4.4.3. Italy Next-generation Sequencing Technology Market by End User
9.2.4.5. Rest of Europe Next-generation Sequencing Technology Market
9.2.4.5.1. Rest of Europe Next-generation Sequencing Technology Market by Technology
9.2.4.5.2. Rest of Europe Next-generation Sequencing Technology Market by Application
9.2.4.5.3. Rest of Europe Next-generation Sequencing Technology Market by End User
9.3. Asia Pacific
9.3.1. Asia Pacific Next-generation Sequencing Technology Market by Technology
9.3.2. Asia Pacific Next-generation Sequencing Technology Market by Application
9.3.3. Asia Pacific Next-generation Sequencing Technology Market by End User
9.3.4. Asia Pacific Next-generation Sequencing Technology Market by Country
9.3.4.1. China Next-generation Sequencing Technology Market
9.3.4.1.1. China Next-generation Sequencing Technology Market by Technology
9.3.4.1.2. China Next-generation Sequencing Technology Market by Application
9.3.4.1.3. China Next-generation Sequencing Technology Market by End User
9.3.4.2. Japan Next-generation Sequencing Technology Market
9.3.4.2.1. Japan Next-generation Sequencing Technology Market by Technology
9.3.4.2.2. Japan Next-generation Sequencing Technology Market by Application
9.3.4.2.3. Japan Next-generation Sequencing Technology Market by End User
9.3.4.3. India Next-generation Sequencing Technology Market
9.3.4.3.1. India Next-generation Sequencing Technology Market by Technology
9.3.4.3.2. India Next-generation Sequencing Technology Market by Application
9.3.4.3.3. India Next-generation Sequencing Technology Market by End User
9.3.4.4. South Korea Next-generation Sequencing Technology Market
9.3.4.4.1. South Korea Next-generation Sequencing Technology Market by Technology
9.3.4.4.2. South Korea Next-generation Sequencing Technology Market by Application
9.3.4.4.3. South Korea Next-generation Sequencing Technology Market by End User
9.3.4.5. Australia Next-generation Sequencing Technology Market
9.3.4.5.1. Australia Next-generation Sequencing Technology Market by Technology
9.3.4.5.2. Australia Next-generation Sequencing Technology Market by Application
9.3.4.5.3. Australia Next-generation Sequencing Technology Market by End User
9.3.4.6. Rest of Asia-Pacific Next-generation Sequencing Technology Market
9.3.4.6.1. Rest of Asia-Pacific Next-generation Sequencing Technology Market by Technology
9.3.4.6.2. Rest of Asia-Pacific Next-generation Sequencing Technology Market by Application
9.3.4.6.3. Rest of Asia-Pacific Next-generation Sequencing Technology Market by End User
9.4. RoW
9.4.1. RoW Next-generation Sequencing Technology Market by Technology
9.4.2. RoW Next-generation Sequencing Technology Market by Application
9.4.3. RoW Next-generation Sequencing Technology Market by End User
9.4.4. RoW Next-generation Sequencing Technology Market by Sub-region
9.4.4.1. Latin America Next-generation Sequencing Technology Market
9.4.4.1.1. Latin America Next-generation Sequencing Technology Market by Technology
9.4.4.1.2. Latin America Next-generation Sequencing Technology Market by Application
9.4.4.1.3. Latin America Next-generation Sequencing Technology Market by End User
9.4.4.2. Middle East Next-generation Sequencing Technology Market
9.4.4.2.1. Middle East Next-generation Sequencing Technology Market by Technology
9.4.4.2.2. Middle East Next-generation Sequencing Technology Market by Application
9.4.4.2.3. Middle East Next-generation Sequencing Technology Market by End User
9.4.4.3. Africa Next-generation Sequencing Technology Market
9.4.4.3.1. Africa Next-generation Sequencing Technology Market by Technology
9.4.4.3.2. Africa Next-generation Sequencing Technology Market by Application
9.4.4.3.3. Africa Next-generation Sequencing Technology Market by End User
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security